In agreement with this evidence, SIRT6 is downregulated in human livers affected by NAFLD [382], suggesting that SIRT6 plays a role in NAFLD through its histone deacetylase activity, and in cholestatic livers [383]. The gene discussed is SIRT6; the disease is metabolic dysfunction-associated steatotic liver disease.